Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 410 participants.
Also called NCT06767345
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 410 participants
- Registry
-
NCT06767345
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06767345. Randomized; no masking; primary purpose treatment. Start 2025-05-12 (actual); primary completion 2027-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization
- Condition
- Coronary Artery Disease
- Condition
- Atherosclerosis of Coronary Artery
- Condition
- Plaque, Atherosclerotic
- Intervention (Drug)
- Rosuvastatin
- Intervention (Drug)
- Rosuvastatin/ezetimibe
- Lead sponsor
- Korea University Anam Hospital
- Collaborator
- Yuhan Corporation
- Collaborator
- Hanmi Pharmaceutical co., ltd.
Record details
- Record id
cardio:ct-nct06767345- Content hash
c7446cbacd02401d797a6ac95758fd26c093a7f908d22da638f0707ffd5d56e7